ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) /

The debt of ARCUTIS BIOTHERAPEUTICS, INC. over the past 8 years

Chart ARCUTIS BIOTHERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2018–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, ARCUTIS BIOTHERAPEUTICS, INC. had liquid cash of $220.98M and total debt of $108.96M: net cash of $112.02M. It had more liquid cash than debt at all 6 year-ends shown. Total debt was highest at the end of fiscal 2023 ($201.8M) and lowest at the end of fiscal 2019 ($0). No net cash figure is on file for fiscal 2024.

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$220.98M*$108.96M$112.02M
2024ended Dec 31, 2024$227.96M*——
2023ended Dec 31, 2023$271.86M*$201.8M$70.06M
2022ended Dec 31, 2022$409.59M*$197.77M$211.82M
2021ended Dec 31, 2021$387.06M*$72.35M$314.71M
2020ended Dec 31, 2020$284.44M*$0$284.44M
2019ended Dec 31, 2019$101.27M*$0$101.27M
2018ended Dec 31, 2018———

Fiscal years as ARCUTIS BIOTHERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ARCUTIS BIOTHERAPEUTICS, INC.

Companies of a similar size

Not investment advice. This page shows what ARCUTIS BIOTHERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.